ドラッグデリバリーデバイスの世界市場レポート 2024年

ドラッグデリバリーデバイス市場規模は、今後数年間で力強い成長が見込まれます。2028年の年間平均成長率（CAGR）は8.8％で、8億6,000万米ドルに成長します。予測期間に予測される成長は、慢性疾患の罹患率の上昇、個別化医療に対する需要の増加、遺伝子治療に対する認識と採用の拡大、非侵襲的・低侵襲的処置に対する需要、患者への直接投与モデルの人気の高まりに起因しています。今後予想される主要動向としては、バイオテクノロジーと遺伝子工学の発展、ドラッグデリバリーシステムの技術改良、研究開発投資の増加、新規デリバリープラットフォームの開発、診断技術の進歩などが挙げられます。

遺伝子治療の採用拡大が、今後のドラッグデリバリーデバイス市場の拡大を牽引すると予想されます。遺伝子治療とは、患者の細胞内に遺伝物質を導入、除去、改変することで、病気の治療や予防を行う医療アプローチです。遺伝子治療に対する需要の高まりは、遺伝性疾患や慢性疾患を根本から解決し、従来の治療法では不十分であった治療に変革をもたらす可能性があることに起因しています。ドラッグデリバリーデバイスは、治療遺伝子の正確なターゲティングと制御された放出を保証することにより、治療の有効性を高める遺伝子治療において重要な役割を果たしています。例えば、2023年11月、米国の科学リソースであるNational Centre for BIoTechnology Informationは、遺伝子治療を受ける新規患者数が2020年の1万6,244人から2025年には9万4,696人に増加すると予測しています。このように、遺伝子治療の普及がドラッグデリバリーデバイス市場の成長を後押ししています。

ドラッグデリバリーデバイス市場の主要企業は、競争優位性を確保するため、人工知能（AI）技術を含む先進製品の開発に注力しています。ドラッグデリバリーにおいてAI技術は、AI技術やアルゴリズムを利用して、デリバリーシステムの効率、精度、有効性を高めるものです。例えば、2023年12月、標的デリバリー用ポリマーベース・ナノ粒子を専門とする米国のEnvoya Inc.は、新しい遺伝子治療デリバリープラットフォームを発表しました。このプラットフォームは、バイオポリマーナノ粒子とAIを統合し、ウイルスベクターや脂質ナノ粒子といった現在の遺伝子治療技術の主要な限界に対処するものです。その目的は、遺伝子治療デリバリーシステムにおける安全性、ペイロード容量、組織ターゲティングに関する既存の課題を克服することです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界の市場規模と成長

• 世界のドラッグデリバリーデバイス市場：促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界のドラッグデリバリーデバイス市場の実績：規模と成長、2018～2023年
• 世界のドラッグデリバリーデバイス市場の予測：規模と成長、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界のドラッグデリバリーデバイス市場：ベクター別、実績と予測、2018～2023年、2023～2028年、2033年
• ウイルス性
• 非ウイルス性
• 世界のドラッグデリバリーデバイス市場：方法別、実績と予測、2018～2023年、2023～2028年、2033年
• In Situ
• Ex Vivo
• 世界のドラッグデリバリーデバイス市場：投与経路別、実績と予測、2018～2023年、2023～2028年、2033年
• 経口
• 吸入
• 経皮
• 注射
• 眼科
• 鼻腔
• 局所

第7章 地域別・国別分析

• 世界のドラッグデリバリーデバイス市場：地域別、実績と予測、2018～2023年、2023～2028年、2033年
• 世界のドラッグデリバリーデバイス市場：国別、実績と予測、2018～2023年、2023～2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ドラッグデリバリーデバイス市場：競合情勢
• ドラッグデリバリーデバイス市場：企業プロファイル
  • Merck & Co. Inc.
  • AbbVie Inc.
  • Bayer AG
  • AstraZeneca plc
  • Medtronic plc

第31章 その他の大手企業と革新的企業

• Amgen Inc.
• Moderna Inc.
• Biogen Inc.
• Sarepta Therapeutics Inc.
• SCIEX
• Halozyme Therapeutics Inc.
• ViiV Healthcare Limited
• Uniqure NV
• Cytokinetics Inc.
• Prothena Corporation plc
• Intellia Therapeutics Inc.
• Voyager Therapeutics Inc.
• sfm medical devices GmbH
• Inovio Pharmaceuticals Inc.
• GenSight Biologics S.A.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の展望と潜在的な分析

第36章 付録

Drug and gene delivery devices are specialized tools designed to transport pharmaceuticals or genetic material into the body for therapeutic purposes. These devices enable targeted treatment of diseases at the molecular level, enhancing precision and efficacy. They play a vital role in advancing personalized medicine by ensuring controlled release and optimal delivery of therapeutic agents to specific cells or tissues, thereby minimizing side effects and maximizing treatment effectiveness.

The main vector types for drug and gene delivery devices include viral and non-viral vectors. Viral gene delivery involves the use of genetically engineered viruses to introduce therapeutic genes into target cells. These methods can be performed in situ (directly within the body) or ex vivo (outside the body, followed by reintroduction). The routes of administration for these devices include oral, inhalation, transdermal, injectable, ocular, nasal, and topical methods.

The drug and gene delivery devices market research report is one of a series of new reports from The Business Research Company that provides drug and gene delivery devices market statistics, including drug and gene delivery devices industry global market size, regional shares, competitors with a drug and gene delivery devices market share, detailed drug and gene delivery devices market segments, market trends and opportunities, and any further data you may need to thrive in the drug and gene delivery devices industry. This drug and gene delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drug and gene delivery devices market size has grown strongly in recent years. It will grow from $0.56 billion in 2023 to $0.61 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The growth during the historic period can be attributed to advancements in healthcare infrastructure, the expansion of personalized gene therapy programs, a greater focus on preventive healthcare, the rising prevalence of rare and orphan diseases, and increased public awareness about health and treatment options.

The drug and gene delivery devices market size is expected to see strong growth in the next few years. It will grow to $0.86 billion in 2028 at a compound annual growth rate (CAGR) of 8.8%. The growth projected for the forecast period can be attributed to the rising incidence of chronic diseases, increasing demand for personalized medicine, greater awareness and adoption of gene therapy, a demand for non-invasive and minimally invasive procedures, and the growing popularity of direct-to-patient delivery models. Key trends expected include advancements in biotechnology and genetic engineering, technological improvements in drug delivery systems, increased investment in research and development, the development of novel delivery platforms, and progress in diagnostic technologies.

The growing adoption of gene therapy is anticipated to drive the expansion of the drug and gene delivery devices market in the future. Gene therapy is a medical approach that involves introducing, removing, or altering genetic material within a patient's cells to treat or prevent diseases. The increasing demand for gene therapy stems from its potential to address genetic disorders and chronic diseases at their source, providing transformative treatment options where conventional therapies may fall short. Drug and gene delivery devices play a crucial role in gene therapy by ensuring precise targeting and controlled release of therapeutic genes, which enhances the effectiveness of treatments. For example, in November 2023, the National Centre for Biotechnology Information, a US-based scientific resource, projected that the number of new patients receiving gene therapies would rise from 16,244 in 2020 to 94,696 by 2025. Thus, the growing adoption of gene therapy is fueling the growth of the drug and gene delivery devices market.

Leading companies in the drug and gene delivery devices market are concentrating on developing advanced products, including artificial intelligence (AI) technology, to secure a competitive advantage. In drug delivery, AI technology involves using AI techniques and algorithms to enhance the efficiency, precision, and effectiveness of delivery systems. For instance, in December 2023, Envoya Inc., a US-based company specializing in polymer-based nanoparticles for targeted delivery, introduced a new gene therapy drug delivery platform. This platform integrates biopolymer nanoparticles with AI to address key limitations of current gene therapy technologies, such as viral vectors and lipid nanoparticles. The goal is to overcome existing challenges related to safety, payload capacity, and tissue targeting in gene therapy delivery systems.

In March 2022, Sandoz Group AG, a Switzerland-based pharmaceutical company, acquired Coalesce Product Development Limited for an undisclosed amount. This acquisition was aimed at enhancing Sandoz's portfolio of respiratory medicines and improving patient access to high-quality, complex therapies. Coalesce Product Development Limited is a UK-based company specializing in medical and drug delivery devices.

Major companies operating in the drug and gene delivery devices market are Merck & Co. Inc., AbbVie Inc., Bayer AG, AstraZeneca plc, Medtronic plc, Amgen Inc., Moderna Inc., Biogen Inc., Sarepta Therapeutics Inc., SCIEX, Halozyme Therapeutics Inc., ViiV Healthcare Limited, Uniqure NV, Cytokinetics Inc., Prothena Corporation plc, Intellia Therapeutics Inc., Voyager Therapeutics Inc., sfm medical devices GmbH, Inovio Pharmaceuticals Inc., GenSight Biologics S.A., CRISPR Therapeutics

North America was the largest region in the drug and gene delivery devices market in 2023. The regions covered in the drug and gene delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drug and gene delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drug and gene delivery devices market consists of sales of microspheres and microneedles, electroporation devices, bioadhesive systems, and gene therapy vectors. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drug And Gene Delivery Devices Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drug and gene delivery devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drug and gene delivery devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drug and gene delivery devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Vector: Viral; Non-viral
• 2) By Method: In Situ; Ex Vivo
• 3) By Route Of Administration: Oral; Inhalation; Transdermal; Injectable; Ocular; Nasal; Topical
• Companies Mentioned: Merck & Co. Inc.; AbbVie Inc.; Bayer AG; AstraZeneca plc; Medtronic plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drug And Gene Delivery Devices Market Characteristics

3. Drug And Gene Delivery Devices Market Trends And Strategies

4. Drug And Gene Delivery Devices Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Drug And Gene Delivery Devices Market Size and Growth

• 5.1. Global Drug And Gene Delivery Devices Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Drug And Gene Delivery Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Drug And Gene Delivery Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Drug And Gene Delivery Devices Market Segmentation

• 6.1. Global Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Viral
• Non-viral
• 6.2. Global Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• In Situ
• Ex Vivo
• 6.3. Global Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral
• Inhalation
• Transdermal
• Injectable
• Ocular
• Nasal
• Topical

7. Drug And Gene Delivery Devices Market Regional And Country Analysis

• 7.1. Global Drug And Gene Delivery Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Drug And Gene Delivery Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Drug And Gene Delivery Devices Market

• 8.1. Asia-Pacific Drug And Gene Delivery Devices Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Drug And Gene Delivery Devices Market

• 9.1. China Drug And Gene Delivery Devices Market Overview
• 9.2. China Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Drug And Gene Delivery Devices Market

• 10.1. India Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Drug And Gene Delivery Devices Market

• 11.1. Japan Drug And Gene Delivery Devices Market Overview
• 11.2. Japan Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Drug And Gene Delivery Devices Market

• 12.1. Australia Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Drug And Gene Delivery Devices Market

• 13.1. Indonesia Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Drug And Gene Delivery Devices Market

• 14.1. South Korea Drug And Gene Delivery Devices Market Overview
• 14.2. South Korea Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Drug And Gene Delivery Devices Market

• 15.1. Western Europe Drug And Gene Delivery Devices Market Overview
• 15.2. Western Europe Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Drug And Gene Delivery Devices Market

• 16.1. UK Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Drug And Gene Delivery Devices Market

• 17.1. Germany Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Drug And Gene Delivery Devices Market

• 18.1. France Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Drug And Gene Delivery Devices Market

• 19.1. Italy Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Drug And Gene Delivery Devices Market

• 20.1. Spain Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Drug And Gene Delivery Devices Market

• 21.1. Eastern Europe Drug And Gene Delivery Devices Market Overview
• 21.2. Eastern Europe Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Drug And Gene Delivery Devices Market

• 22.1. Russia Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Drug And Gene Delivery Devices Market

• 23.1. North America Drug And Gene Delivery Devices Market Overview
• 23.2. North America Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Drug And Gene Delivery Devices Market

• 24.1. USA Drug And Gene Delivery Devices Market Overview
• 24.2. USA Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Drug And Gene Delivery Devices Market

• 25.1. Canada Drug And Gene Delivery Devices Market Overview
• 25.2. Canada Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Drug And Gene Delivery Devices Market

• 26.1. South America Drug And Gene Delivery Devices Market Overview
• 26.2. South America Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Drug And Gene Delivery Devices Market

• 27.1. Brazil Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Drug And Gene Delivery Devices Market

• 28.1. Middle East Drug And Gene Delivery Devices Market Overview
• 28.2. Middle East Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Drug And Gene Delivery Devices Market

• 29.1. Africa Drug And Gene Delivery Devices Market Overview
• 29.2. Africa Drug And Gene Delivery Devices Market, Segmentation By Vector, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Drug And Gene Delivery Devices Market, Segmentation By Method, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Drug And Gene Delivery Devices Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Drug And Gene Delivery Devices Market Competitive Landscape And Company Profiles

• 30.1. Drug And Gene Delivery Devices Market Competitive Landscape
• 30.2. Drug And Gene Delivery Devices Market Company Profiles
  • 30.2.1. Merck & Co. Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. AbbVie Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Bayer AG
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. AstraZeneca plc
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Medtronic plc
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Drug And Gene Delivery Devices Market Other Major And Innovative Companies

• 31.1. Amgen Inc.
• 31.2. Moderna Inc.
• 31.3. Biogen Inc.
• 31.4. Sarepta Therapeutics Inc.
• 31.5. SCIEX
• 31.6. Halozyme Therapeutics Inc.
• 31.7. ViiV Healthcare Limited
• 31.8. Uniqure NV
• 31.9. Cytokinetics Inc.
• 31.10. Prothena Corporation plc
• 31.11. Intellia Therapeutics Inc.
• 31.12. Voyager Therapeutics Inc.
• 31.13. sfm medical devices GmbH
• 31.14. Inovio Pharmaceuticals Inc.
• 31.15. GenSight Biologics S.A.

32. Global Drug And Gene Delivery Devices Market Competitive Benchmarking

33. Global Drug And Gene Delivery Devices Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Drug And Gene Delivery Devices Market

35. Drug And Gene Delivery Devices Market Future Outlook and Potential Analysis

• 35.1 Drug And Gene Delivery Devices Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Drug And Gene Delivery Devices Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Drug And Gene Delivery Devices Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer